Wall Street Sector Selector's John Nyaradi On Fox Business News
John Nyaradi speaks with Fox Business News on Election Day 2012 to discuss which sectors would better perform under an Obama second term.
Under an Obama 2nd term, John suggests that the healthcare sector, including healthcare ETFs like the Health Care SPDR ETF (NYSEARCA:XLV) and the Vanguard Healthcare ETF (NYSEARCA:VHT), will see increased profits, as Obamacare legislation coupled with “baby boom” retirements will surely boost prices. John also suggests that an Obama Administration would further encourage clean energy and alternative energy research and spending, which would likely draw more attention and profits to clean energy ETFs such as the PowerShares Global Wind Energy ETF (NYSEARA:PWND), the iShares S&P Global Clean Energy ETF (NYSEARCA:ICLN), and the Market Vectors Global Alternative Energy ETF (NSYEARCA:GEX).
Although oil prices will likely continue to rise under both and Obama and a Romney Presidency, oil ETFs such as the United States Oil Fund LP ETF (NYSEARCA:USO) and the iPath S&P GSCI Crude Oil Total Return ETN (NYSEARCA:OIL) will likely benefit further under a Romney Presidency, as a win for Romney would most likely be a win for “big oil” as well. The Defense Sector and defense ETFs including the PowerShares Aerospace & Defense Portfolio (NYSEARCA:PPA) and the iShares Dow Jones US Aerospace & Defense ETF (NYSEARCA:ITA) would also likely see more profit gains under a Romney Administration, as Romney vowed to increase military spending during his campaign.
Bottom Line: Now that we know President Obama will serve a second term, good sector ETF plays would likely include healthcare ETFs such as NYSEARCA:XLV and NYSEARCA:VHT and alternative energy ETFs such as NYSEARCA:GEX and NYSEARCA:ICLN. Oil ETFs like NYSEARCA:USO and defense ETFs like NYSEARCA:PPA would also likely be good plays under President Obama, as both oil and defense are still vital and necessary forces in our economy.
The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.